Functionalised cyclopentadienyl zirconium compounds as potential anticancer drugs.
Olivia R Allen, Richard J Knox, Patrick C McGowan
Index: Dalton Trans. (39) , 5293-5, (2008)
Full Text: HTML
Abstract
New neutral and ionic functionalised zirconocene dichloride compounds have been isolated and characterised. The ionic zirconocene exhibits excellent cytotoxicity against a range of human tumour cell lines, which represents the first active anticancer zirconocene dichloride compound.
Related Compounds
Related Articles:
Unusual temperature effects in propene polymerization using stereorigid zirconocene catalysts.
2003-02-15
[ChemPhysChem 6(9) , 1929-33, (2005)]
Enantioselective route from carbohydrates to cyclooctane polyols.
2005-02-03
[Org. Lett. 7(3) , 511-3, (2005)]
2008-08-15
[J. Org. Chem. 73(16) , 6202-6, (2008)]
In pursuit of pestalotiopsin a via zirconocene-mediated ring contraction.
2006-05-25
[Org. Lett. 8(11) , 2429-31, (2006)]
A selective synthesis of hydroxyborate anions as novel anchors for zirconocene catalysts.
2008-06-07
[Dalton Trans. (21) , 2866-70, (2008)]